September 6, 2023 11:21 AM EDT
News Briefing

Mer­sana CEO to step down af­ter eight years; Roy­al­ty Phar­ma pays $150M for Skytro­fa roy­al­ties

Tyler Patchen

News Reporter

Paul Schloesser

Associate Editor

Mer­sana Ther­a­peu­tics said Wednes­day that pres­i­dent and CEO An­na Pro­topa­pas is re­tir­ing Sept. 10, and board mem­ber Mar­tin Hu­ber will take …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times